Problem

G LNK addresses the costly, slow, and fragmented process pharmaceutical, biotech, and medtech companies use to identify, engage, and compensate healthcare professionals. The company’s launch materials describe more than $70 billion in annual pharma spending on doctor and researcher engagement, much of it absorbed by consulting, recruiting, and regulatory intermediaries. The pain is not only economic: manual searches waste time, compensation errors create compliance exposure, and contracts, payments, and regulatory records sit across disconnected systems.

The central use case is finding the right key opinion leaders, physicians, or researchers for drug development and commercialization, then determining what to pay them compliantly. A process that traditionally requires expensive third parties and can take weeks is intended to collapse into a faster, more defensible workflow for commercial, medical-affairs, and compliance teams.

Product / Service

G LNK is an AI-powered healthcare commercial-intelligence platform and B2B SaaS product. Its searchable database combines more than 9.2 million clinician profiles with prescribing and treatment analytics, institutional data, procedure and claims information, medical-device utilization, Open Payments records, and fair-market-value benchmarks. Users can search in natural language for clinicians, procedures, specialties, or publications, or upload a physician’s CV; the platform then ranks and tiers candidates and estimates compensation.

The workflow continues through engagement and compliance: teams can contact and track clinicians in a built-in CRM, monitor transfer-of-value payments, and check regulatory requirements across more than 150 countries. G LNK sells annual Health Explorer subscriptions and team plans, with higher tiers adding market and competitive analytics, collaboration tools, referral-network mapping, API access, integrations, and account support. The intended benefit is to replace multiple data vendors and service providers with one self-service system that makes expert selection faster, compensation more defensible, and oversight easier.

Market

G LNK competes in healthcare commercial intelligence, life-sciences data, and vertical AI for pharma, biotech, and medtech. Its named or adjacent competitors include IQVIA, Veeva, Definitive Healthcare, H1, and Komodo Health, as well as the consulting, recruiting, and regulatory firms that traditionally manage HCP engagement. G LNK’s differentiation is its focus on the engagement-and-compensation workflow, combining natural-language clinician search with fair-market-value benchmarking and compliance rather than offering only a broad enterprise data repository.

The company was founded in 2024, joined Y Combinator’s Winter 2025 batch, and is listed as an active B2B SaaS health-tech company. Its current site presents a live subscription product with enterprise plans and access to substantial data assets, including 9.2 million-plus profiles, billions of claims, and more than $11 billion in tracked payments. Public evidence indicates an early commercial stage, but the reviewed materials do not disclose a customer count or verified revenue figure, so G LNK should not be labeled definitively pre-revenue; its traction is better characterized as an active, recently launched startup with a live product and institutional backing.